These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 16322256)
1. Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells. Paglin S; Lee NY; Nakar C; Fitzgerald M; Plotkin J; Deuel B; Hackett N; McMahill M; Sphicas E; Lampen N; Yahalom J Cancer Res; 2005 Dec; 65(23):11061-70. PubMed ID: 16322256 [TBL] [Abstract][Full Text] [Related]
2. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Mungamuri SK; Yang X; Thor AD; Somasundaram K Cancer Res; 2006 May; 66(9):4715-24. PubMed ID: 16651424 [TBL] [Abstract][Full Text] [Related]
3. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells. Chang SB; Miron P; Miron A; Iglehart JD J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887 [TBL] [Abstract][Full Text] [Related]
4. Phospholipase D confers rapamycin resistance in human breast cancer cells. Chen Y; Zheng Y; Foster DA Oncogene; 2003 Jun; 22(25):3937-42. PubMed ID: 12813467 [TBL] [Abstract][Full Text] [Related]
5. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells. Fang CX; Yang X; Sreejayan N; Ren J Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100 [TBL] [Abstract][Full Text] [Related]
6. Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells. Roforth MM; Tan C Anticancer Drugs; 2008 Aug; 19(7):681-8. PubMed ID: 18594209 [TBL] [Abstract][Full Text] [Related]
7. Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells. Iwamaru A; Kondo Y; Iwado E; Aoki H; Fujiwara K; Yokoyama T; Mills GB; Kondo S Oncogene; 2007 Mar; 26(13):1840-51. PubMed ID: 17001313 [TBL] [Abstract][Full Text] [Related]
8. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341 [TBL] [Abstract][Full Text] [Related]
9. IGF-I, EGF, and sex steroids regulate autophagy in bovine mammary epithelial cells via the mTOR pathway. Sobolewska A; Gajewska M; ZarzyĆska J; Gajkowska B; Motyl T Eur J Cell Biol; 2009 Feb; 88(2):117-30. PubMed ID: 19013662 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway. Pervin S; Singh R; Hernandez E; Wu G; Chaudhuri G Cancer Res; 2007 Jan; 67(1):289-99. PubMed ID: 17210710 [TBL] [Abstract][Full Text] [Related]
11. The PCPH oncoprotein antagonizes the proapoptotic role of the mammalian target of rapamycin in the response of normal fibroblasts to ionizing radiation. Tirado OM; Mateo-Lozano S; Sanders S; Dettin LE; Notario V Cancer Res; 2003 Oct; 63(19):6290-8. PubMed ID: 14559816 [TBL] [Abstract][Full Text] [Related]
12. Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Daido S; Kanzawa T; Yamamoto A; Takeuchi H; Kondo Y; Kondo S Cancer Res; 2004 Jun; 64(12):4286-93. PubMed ID: 15205343 [TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro. Gorshtein A; Rubinfeld H; Kendler E; Theodoropoulou M; Cerovac V; Stalla GK; Cohen ZR; Hadani M; Shimon I Endocr Relat Cancer; 2009 Sep; 16(3):1017-27. PubMed ID: 19509067 [TBL] [Abstract][Full Text] [Related]
14. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128 [TBL] [Abstract][Full Text] [Related]
15. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Aoki H; Takada Y; Kondo S; Sawaya R; Aggarwal BB; Kondo Y Mol Pharmacol; 2007 Jul; 72(1):29-39. PubMed ID: 17395690 [TBL] [Abstract][Full Text] [Related]
16. Licorice and licochalcone-A induce autophagy in LNCaP prostate cancer cells by suppression of Bcl-2 expression and the mTOR pathway. Yo YT; Shieh GS; Hsu KF; Wu CL; Shiau AL J Agric Food Chem; 2009 Sep; 57(18):8266-73. PubMed ID: 19711916 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model. Wu Q; Kiguchi K; Kawamoto T; Ajiki T; Traag J; Carbajal S; Ruffino L; Thames H; Wistuba I; Thomas M; Vasquez KM; DiGiovanni J Cancer Res; 2007 Apr; 67(8):3794-800. PubMed ID: 17440093 [TBL] [Abstract][Full Text] [Related]
18. Monitoring mammalian target of rapamycin (mTOR) activity. Ikenoue T; Hong S; Inoki K Methods Enzymol; 2009; 452():165-80. PubMed ID: 19200882 [TBL] [Abstract][Full Text] [Related]
19. Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Hashimoto I; Koizumi K; Tatematsu M; Minami T; Cho S; Takeno N; Nakashima A; Sakurai H; Saito S; Tsukada K; Saiki I Eur J Cancer; 2008 May; 44(7):1022-9. PubMed ID: 18375114 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of ribosomal p70 S6 kinase and rapamycin sensitivity in human colorectal cancer. Nozawa H; Watanabe T; Nagawa H Cancer Lett; 2007 Jun; 251(1):105-13. PubMed ID: 17175097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]